Source: Oncology reports. Unidade: FM
Subjects: EXPRESSÃO GÊNICA, NEOPLASIAS MAMÁRIAS (GENÉTICA), BIOMARCADORES, RECIDIVA LOCAL DE NEOPLASIA, ESTADIAMENTO DE NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOGULLO, Angela F. et al. C-erbB-2 expression is a better predictor for survival than galectin-3 or p53 in early-stage breast cancer. Oncology reports, v. 18, p. 121-126, 2007Tradução . . Disponível em: https://doi.org/10.3892/or.18.1.121. Acesso em: 14 maio 2024.APA
Logullo, A. F., Lopes, A. B. G., Nonogaki, S., Soares, F. A., Mourão Netto, M., Nishimoto, I. N., & Brentani, M. M. (2007). C-erbB-2 expression is a better predictor for survival than galectin-3 or p53 in early-stage breast cancer. Oncology reports, 18, 121-126. doi:10.3892/or.18.1.121NLM
Logullo AF, Lopes ABG, Nonogaki S, Soares FA, Mourão Netto M, Nishimoto IN, Brentani MM. C-erbB-2 expression is a better predictor for survival than galectin-3 or p53 in early-stage breast cancer [Internet]. Oncology reports. 2007 ; 18 121-126.[citado 2024 maio 14 ] Available from: https://doi.org/10.3892/or.18.1.121Vancouver
Logullo AF, Lopes ABG, Nonogaki S, Soares FA, Mourão Netto M, Nishimoto IN, Brentani MM. C-erbB-2 expression is a better predictor for survival than galectin-3 or p53 in early-stage breast cancer [Internet]. Oncology reports. 2007 ; 18 121-126.[citado 2024 maio 14 ] Available from: https://doi.org/10.3892/or.18.1.121